These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 36460263

  • 1. Rejection and graft outcomes in kidney transplant recipients with and without angiotensin II receptor type 1 antibodies.
    Aljishi M, Isbel NM, Jegatheesan D, Johnson DW, Cho Y, Campbell SB, Hawley CM, Thornton A, Gillis D, Johnstone K.
    Transpl Immunol; 2023 Feb; 76():101756. PubMed ID: 36460263
    [Abstract] [Full Text] [Related]

  • 2. Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients.
    Fichtner A, Süsal C, Schröder C, Höcker B, Rieger S, Waldherr R, Westhoff JH, Sander A, Dragun D, Tönshoff B.
    Nephrol Dial Transplant; 2018 Jun 01; 33(6):1065-1072. PubMed ID: 29444269
    [Abstract] [Full Text] [Related]

  • 3. Effect of angiotensin II type 1 receptor antibodies on graft function and survival in paediatric kidney transplant recipients.
    Kermond RF, Kim S, Mackie F, Hahn D, Carroll RP, Sharma A, Durkan AM.
    HLA; 2024 Sep 01; 104(3):e15649. PubMed ID: 39247998
    [Abstract] [Full Text] [Related]

  • 4. Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.
    Liu C, Kang ZY, Yin Z, Xiao Y, Liu W, Zhao Y, Li DH.
    Transpl Immunol; 2022 Oct 01; 74():101674. PubMed ID: 35901953
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of AT1R antibody (AT1R-Ab) among Malaysian multi-ethnic population.
    Jalalonmuhali M, Caroll R, Deayton S, Emery T, Humphreys I, Lim SJ, Lim SK, Coates T.
    Hum Immunol; 2020 Dec 01; 81(12):679-684. PubMed ID: 32736900
    [Abstract] [Full Text] [Related]

  • 6. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C, Viglietti D, Bouatou Y, Philippe A, Pievani D, Aubert O, Duong Van Huyen JP, Taupin JL, Glotz D, Legendre C, Loupy A, Halloran PF, Dragun D.
    Kidney Int; 2019 Jul 01; 96(1):189-201. PubMed ID: 31005275
    [Abstract] [Full Text] [Related]

  • 7. Association of positive pre-transplant angiotensin II type 1 receptor antibodies with clinical outcomes in lung transplant recipients.
    Son BS, Lee HJ, Cho WH, So MW, Park JM, Yeo HJ.
    Transpl Immunol; 2023 Oct 01; 80():101901. PubMed ID: 37442212
    [Abstract] [Full Text] [Related]

  • 8. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Zmonarski S, Protasiewicz M, Nowakowska B, Hałoń A, Chudoba P, Klinger M.
    Transpl Int; 2014 Oct 01; 27(10):1029-38. PubMed ID: 24909812
    [Abstract] [Full Text] [Related]

  • 9. The early impact of preformed angiotensin II type 1 receptor antibodies on graft function in a low immunological risk cohort of kidney transplant recipients.
    Sorohan BM, Ismail G, Berechet A, Obrișcă B, Constantinescu I, Mărunțelu I, Tacu D, Baston C, Sinescu I.
    Transpl Immunol; 2021 Jun 01; 66():101389. PubMed ID: 33838295
    [Abstract] [Full Text] [Related]

  • 10. Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies.
    Lim MA, Palmer M, Trofe-Clark J, Bloom RD, Jackson A, Philogene MC, Kamoun M.
    Hum Immunol; 2017 Apr 01; 78(4):350-356. PubMed ID: 28284829
    [Abstract] [Full Text] [Related]

  • 11. Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis.
    Kang ZY, Liu C, Liu W, Li DH.
    Nephrol Dial Transplant; 2022 May 25; 37(6):1171-1180. PubMed ID: 34865146
    [Abstract] [Full Text] [Related]

  • 12. Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies.
    Gold A, Fichtner A, Choukair D, Schmitt CP, Süsal C, Dragun D, Tönshoff B.
    Pediatr Nephrol; 2021 Mar 25; 36(3):725-729. PubMed ID: 33355703
    [Abstract] [Full Text] [Related]

  • 13. Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection.
    Crespo M, Llinàs-Mallol L, Redondo-Pachón D, Butler C, Gimeno J, Pérez-Sáez MJ, Burballa C, Buxeda A, Arias-Cabrales C, Folgueiras M, Sanz-Ureña S, Valenzuela NM, Reed EF, Pascual J.
    Front Immunol; 2021 Mar 25; 12():703457. PubMed ID: 34305943
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II type 1 receptor antibodies in kidney transplantation: An evidence-based comprehensive review.
    Sorohan BM, Ismail G, Leca N, Tacu D, Obrișcă B, Constantinescu I, Baston C, Sinescu I.
    Transplant Rev (Orlando); 2020 Oct 25; 34(4):100573. PubMed ID: 33002671
    [Abstract] [Full Text] [Related]

  • 15. Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.
    Pearl MH, Chen L, Zuckerman JE, Weng PL, Chambers ET, Zhang Q, Reed EF.
    Transplantation; 2024 Jan 01; 108(1):276-283. PubMed ID: 37527494
    [Abstract] [Full Text] [Related]

  • 16. Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: An observational cohort study.
    Pizzo H, Mirocha J, Choi J, Garrison J, Haas M, Zhang X, Kamil ES, Kim I, Jordan SC, Puliyanda DP.
    Pediatr Transplant; 2022 Dec 01; 26(8):e14400. PubMed ID: 36168673
    [Abstract] [Full Text] [Related]

  • 17. Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients.
    Fichtner A, Süsal C, Höcker B, Rieger S, Waldherr R, Westhoff JH, Sander A, Dragun D, Tönshoff B.
    Pediatr Nephrol; 2021 Aug 01; 36(8):2473-2484. PubMed ID: 33759004
    [Abstract] [Full Text] [Related]

  • 18. Deleterious effect of anti-angiotensin II type 1 receptor antibodies detected pretransplant on kidney graft outcomes is both proper and synergistic with donor-specific anti-HLA antibodies.
    Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Nephrology (Carlton); 2019 Mar 01; 24(3):347-356. PubMed ID: 29451342
    [Abstract] [Full Text] [Related]

  • 19. Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies.
    Philogene MC, Bagnasco S, Kraus ES, Montgomery RA, Dragun D, Leffell MS, Zachary AA, Jackson AM.
    Transplantation; 2017 Mar 01; 101(3):608-615. PubMed ID: 27222934
    [Abstract] [Full Text] [Related]

  • 20. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M, Carroll RP, Tsiopelas E, Clayton P, Coates PT.
    Hum Immunol; 2020 Jul 01; 81(7):323-329. PubMed ID: 32327243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.